We invest in early companies that develop ideas and research from Uppsala University.

Currently

Show:

me

International research collaboration brings hope for glioblastoma treatment

Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer. The startup is preparing clinical trials to create a drug aimed at extending patients’ lives.

vinnarna av venturechallenge2024

The duo behind SoundSim360 – Winners of VentureChallenge 2024

SoundSim360, developed by Professor Ken Mattsson and Dr. Gustav Eriksson, is an advanced sound simulation tool for precise sound level predictions that handles complex acoustics, including low-frequency sounds for wind turbines, arenas, and home theater systems.

Collaboration graphic visual. Teamwork graphics.

From Research to Business – Collaboration between UU Innovation and UU Invest shorten your time to market

UU Invest hosts your project so that you can establish necessary agreements with collaborative partners, hire key personnel to investigate or develop the concept, and also assist ‘hands on’ in negotiations and strategic work.

Ida-Maria Sintorn portrait

SimSearch – New powerful tool in the work with biological microscope images

Ida-Maria Sintorn, along with her colleagues in the SimSearch project, is developing new technology for image processing of microscopic images. The focus is to make it easier, faster, and safer for researchers to extract relevant information from large amounts of data while retaining control over their own data.

CEO of HyEnGen Oscar Verho

HyEnGen – Pioneering Research for Sustainable Energy Production

Oscar Verho and his research network are focused on creating more efficient ways to produce fuels from water. The path involves advanced interdisciplinary development and a sustainable, efficient electrode with the potential to make green hydrogen production more cost-effective.

Matteo, en av Paperhives grundare.

AI accelerates evidence-based clinical decisions

PapersHive is one of UU Invest’s 55 portfolio companies. With an AI-based search technology, the company collects information from all medical databases in one place. This saves both time and money for pharmaceutical companies, CROs and medical technology companies.

Graphic footage with text that describes that venturechallenge 2023 is now closed.

Applications for VentureChallenge 2023 are now closed

Applications for VentureChallenge 2023 are now closed. A new call for applications will open again in the first quarter of 2024.

VentureChallenge text

VentureChallenge 2023

Up to 500,000 SEK for your research-based business idea. UU Invest, in collaboration with UU Innovation, is now conducting a call for start-up capital of up to 500,000 SEK for your research-based business idea.

Tv. Gunilla Lundmark
Verkställande direktör UU Invest

Th. Malin Graffner Nordberg
Chef vid Uppsala universitet Innovation (UU Innovation)

Foto Mikael Wallerstedt

Successful collaboration delivers results

Meet Gunilla Lundmark, CEO of UU Invest, and Malin Graffner Nordberg, Head of UU Innovation. With different roles and expertise, they work towards the same overall goal – to contribute to Uppsala University’s efforts to take research forward and utilise knowledge in society.

Linus Bosaeus, VD för Rarity Bioscience

Precisionsdiagnostik i fokus för Rarity Bioscience

Ulf Landegren och hans forskningsgrupp ligger bakom banbrytande forskning som lett till nya innovationer som framgångsrikt förvaltats och utvecklats i en rad olika bolag. Rarity Bioscience med vd Linus Bosaeus är ett av de senaste i raden.